We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDSCO Steps Up Controls on Clinical Trials in India With 14 New Regs
CDSCO Steps Up Controls on Clinical Trials in India With 14 New Regs
August 26, 2014
Clinical trial investigators in India must limit their work to no more than three trials at any given time, according to one of the mandates in 14 finalized regulations issued by the Central Drugs Standard Control Organization.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor